TCR2 THERAPEUTICS INC. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (4)
- Human Resources (3)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (4)
- Assignment of Lease by and between TCR2 Therapeutics Inc. and AstraZeneca Pharmaceuticals LP, dated May 23, 2023 (Filed With SEC on May 24, 2023)
- Lease Modification Agreement by and between TCR2 Therapeutics Inc. and ARE-Maryland No. 31, LLC, dated May 23, 2023 (Filed With SEC on May 24, 2023)
- Agreement and Plan of Merger, dated as of March 5, 2023, by and among TCR2 Therapeutics Inc., Adaptimmune Therapeutics plc and CM Merger Sub, Inc (Filed With SEC on March 6, 2023)
- Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain stockholders of TCR2 (Filed With SEC on March 6, 2023)
- Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain shareholders of Adaptimmune (Filed With SEC on March 6, 2023)
- Form of Executive Agreement Amendment (Filed With SEC on March 6, 2023)
- 2022 Inducement Plan and forms of award agreements thereunder (Filed With SEC on March 22, 2022)
- Lease Agreement, dated as of March 23, 2021, by and between ARE-Maryland No. 31, LLC and the Registrant (Filed With SEC on May 13, 2021)
- Description of Registrants Securities (Filed With SEC on March 16, 2021)
- Underwriting Agreement, dated January 19, 2021, by and among TCR2 Therapeutics Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Piper Sandler & Co. and BMO Capital Markets, as... (Filed With SEC on January 22, 2021)
- Underwriting Agreement, dated July 28, 2020, by and among TCR2 Therapeutics Inc., Jefferies LLC, SVB Leerink LLC, Piper Sandler & Co. and BMO Capital Markets, as representatives... (Filed With SEC on July 31, 2020)
- Description of Registrants Securities (Filed With SEC on March 30, 2020)
- Amendment No. 1 to 2018 Stock Option and Incentive Plan (Filed With SEC on May 13, 2019)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2019)
- Form of Specimen Common Stock Certificate (Filed With SEC on February 1, 2019)
- 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on February 1, 2019)
- 2018 Employee Stock Purchase Plan (Filed With SEC on February 1, 2019)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated February 28, 2018 (Filed With SEC on December 28, 2018)
- Form of Common Stock Warrant (Filed With SEC on December 28, 2018)
- 2015 Stock Option and Grant Plan and forms of award agreements thereunder (Filed With SEC on December 28, 2018)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on December 28, 2018)
- Form of Director Indemnification Agreement (Filed With SEC on December 28, 2018)
- Form of Officer Indemnification Agreement (Filed With SEC on December 28, 2018)
